Neuroinflammatory Proteins in Huntington's Disease: Insights into Mechanisms, Diagnosis, and Therapeutic Implications

Area of Science:

• Neuroscience
• Immunology
• Genetics

Background:

• Huntington's disease (HD) is a hereditary neurodegenerative disorder linked to CAG repeat expansion in the huntingtin gene (HTT).
• Neuroinflammation, involving glial cells, is an early pathological hallmark in HD and other neurodegenerative diseases (NDDs).
• The specific role and therapeutic implications of inflammation in HD remain less explored compared to other NDDs.

Purpose of the Study:

• To review the evidence for neuroinflammation in Huntington's disease.
• To highlight the roles of glial cells and the peripheral immune system in HD pathogenesis.
• To discuss the therapeutic potential of targeting inflammation in HD.

Main Methods:

• Review of scientific literature on HD, neuroinflammation, and immunology.
• Analysis of data from HD animal models and human patient tissues.
• Synthesis of recent findings on immune system involvement in HD.

Main Results:

• Elevated inflammatory proteins and cellular markers are consistently observed in HD models and patients.
• Microglia, astrocytes, and oligodendrocytes play critical roles in mediating HD neuroinflammation.
• Emerging evidence points to the involvement of the peripheral immune system in HD.

Conclusions:

• Neuroinflammation is a significant factor in Huntington's disease progression.
• Targeting inflammation, alongside other therapies and personalized approaches, shows promise for HD treatment.
• Further research into immunomodulatory strategies and biomarkers is warranted for HD diagnosis and therapy.